Incidence and clinical outcome of abrupt vessel closure among patients receiving Abciximab during high-risk percutaneous coronary intervention: EPIC trial results

被引：0

作者：

Aguirre, FV ^{[1
]}

Topol, EJ ^{[1
]}

Leimberger, J ^{[1
]}

Kleiman, N ^{[1
]}

Lincoff, AM ^{[1
]}

Donohue, TJ ^{[1
]}

Califf, RM ^{[1
]}

机构：

[1] ST LOUIS UNIV,CTR HLTH SCI,ST LOUIS,MO 63103

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 1997年 / 29卷 / 02期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：8011 / 8011

页数：1

共 50 条

[21] Routine functional testing after percutaneous coronary intervention: results of the Aggressive Diagnosis of Restenosis in High-Risk Patients (ADORE II) trial
Eisenberg, Mark J.
Wilson, Brooke
Lauzon, Claude
Huynh, Thao
Eisen-Hauer, Michael
Mak, Koon Hou
Blankenship, James C.
Doucet, Michel
Pilote, Louise
ACTA CARDIOLOGICA, 2007, 62 (02) : 143 - 150
[22] Efficacy and Safety of the HeartMate Percutaneous Heart Pump During High-Risk Percutaneous Coronary Intervention (from the SHIELD I Trial)
Dudek, Dariusz
Ebner, Drian
Sobczynski, Robert
Trebacz, Jaroslaw
Vesga, Boris
Granada, Juan
Zembala, Marian
Witkowski, Adam
Van Mieghem, Nicolas M.
Sood, Poornima
Ochala, Andrzej
Dziewierz, Artur
Zmudka, Krzysztof
AMERICAN JOURNAL OF CARDIOLOGY, 2018, 121 (12): : 1524 - 1529
[23] Is there a gender-related difference in the abciximab effects in high-risk patients with acute coronary syndrome undergoing percutaneous coronary intervention? Lessons from ISAR-REACT 2 trial
Mehilli, J.
Kastrati, A.
Bruskina, O.
Pache, J.
Dirschinger, J.
Schomig, A.
EUROPEAN HEART JOURNAL, 2006, 27 : 449 - 449
[24] Rheolytic Thrombectomy during Percutaneous Coronary Intervention Improves Long-Term Outcome in High-Risk Patients with Acute Myocardial Infarction
De Rosa, Salvatore
Cirillo, Plinio
De Luca, Giuseppe
Galasso, Gennaro
Esposito, Giovanni
Leosco, Dario
Piscione, Federico
Chiariello, Massimo
JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2007, 20 (04) : 292 - 298
[25] A multicenter, randomized trial of percutaneous coronary intervention versus bypass surgery in high-risk unstable angina patients
Morrison, DA
Sethi, G
Sacks, J
Grover, F
Sedlis, S
Esposito, R
Ramanathan, KB
Weiman, D
Krucoff, M
Duhaylongsod, F
Raya, T
Pett, S
Vernon, S
Birjiniuk, V
Booth, D
Robinson, C
Talley, JD
Antckli, T
Murphy, E
Floten, H
Curcovic, V
Lucke, JC
Lewis, D
Barbiere, C
Henderson, W
CONTROLLED CLINICAL TRIALS, 1999, 20 (06): : 601 - 619
[26] Diabetes-dependent analysis of the effects of abciximab in high-risk patients with acute coronary syndrome undergoing percutaneous coronary intervention. Lessons from ISAR-REACT 2 Trial
Volmer, C.
Bollwein, H.
Mehilli, J.
Ten Berg, J.
Neumann, F. -J.
Dirschinger, J.
Kastrati, A.
Schomig, A.
EUROPEAN HEART JOURNAL, 2006, 27 : 759 - 759
[27] Clinical benefit within patient subgroups receiving c7E3 Fab (Abciximab) during percutaneous coronary revascularization: Subgroup analysis from the EPIC trial
Aguirre, FV
Topol, EJ
Anderson, KM
Kleiman, NS
Weisman, HE
FitzPatrick, SE
Califf, RM
JOURNAL OF INVASIVE CARDIOLOGY, 1996, 8 : B21 - B29
[28] Clinical outcome in diabetic patients with multi-vessel coronary artery disease treated with percutaneous coronary intervention compared to coronary bypass surgery: Results from the stent or surgery (SOS) trial
Booth, J
Stables, RH
Clayton, T
Nugara, F
Pepper, J
Sigwart, U
HEART, 2003, 89 : A18 - A19
[29] Elective Intra-aortic Balloon Counterpulsation During High-Risk Percutaneous Coronary Intervention A Randomized Controlled Trial
Perera, Divaka
Stables, Rodney
Thomas, Martyn
Booth, Jean
Pitt, Michael
Blackman, Daniel
de Belder, Adam
Redwood, Simon
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (08): : 867 - 874
[30] Percutaneous coronary intervention during extracorporeal membrane oxygenation versus coronary artery bypass graft surgery in high-risk patients
Kochergin, N.
Ganyukov, V.
Shukevich, D.
EUROPEAN HEART JOURNAL, 2015, 36 : 488 - 488

← 1 2 3 4 5 →